JACKSON, Miss., Nov. 8, 2019 /PRNewswire/ -- Allwell from Magnolia Health announces a partnership with the National Council on Aging (NCOA) to help prevent falls among Medicare Advantage beneficiariesFalls are a leading cause of injury for people aged 65 and older and can threaten their safety and independence, as well as generate great economic and personal

CHICAGO, Nov. 8, 2019 /PRNewswire/ -- In an era of shifting consumer expectations, a healthcare system often described as dysfunctional and high levels of physician burnout, it's particularly noteworthy to report the uniformly excellent satisfaction ratings concierge medicine receives from doctors and patients alike. According to Specialdocs Consultants'

BOSTON, Nov. 8, 2019 /PRNewswire/ -- (NASDAQ: EXAS) – A new study of 443 patients by Exact Sciences Corp. and its collaborators demonstrated 80% sensitivity at 90% specificity with a novel combination of six blood-based biomarkers for the most common type of liver cancer, hepatocellular carcinoma (HCC)i. The study also showed 71% sensiti

PETERBOROUGH, N.H., Nov. 8, 2019 /PRNewswire/ -- SoClean, the creator of SoClean 2, announced today that it has been named by Deloitte as one of America's fastest growing technology companies for the

NEWPORT BEACH, Calif., Nov. 8, 2019 /PRNewswire/ -- Neurologics, an innovative company that applies proprietary technology to optimize and permanently improve brain function, announced today that Colonel (retired) Dallas C. Hack, MD, MPH has joined the company as Chairman of the Scientific Advisory Board. "We are so honored to h

STOCKHOLM, Nov. 8, 2019 /PRNewswire/ -- After a period of assessment of Ortoma's surgical system for hip surgery, the company is now taking the step next step and initiates expansion of Ortoma Treatment Solution (OTS) with a module also for spine surgery.– The conclusion after a number of performed surgeries is that our surgical system provides dis

RARITAN, N.J., Nov. 8, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking approval to expand the IMBRUVICA® (ibrutinib) label to include the combination with rituximab for the first-line tr

VANCOUVER, Nov. 8, 2019 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN; OTCQX: IMLFF), a biopharmaceutical company developing a proprietary biosynthesis manufacturing technology for the production of pharmaceutical-grade cannabinoids as well as a pipeline of medications targeting diseases with high unmet medical needs, today reported

HAMPTON, N.H., Nov. 8, 2019 /PRNewswire/ -- Planet Fitness, Inc. (NYSE: PLNT), one of the largest and fastest-growing franchisors and operators of fitness centers in the U.S., today announced the Company's international expansion to Australia. The country's first official Judgement Free Zones® are located in Tuggerah and Gosford

NORTH CHICAGO, Ill., Nov. 8, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for IMBRUVICA® (ibrutinib) in combination with rituximab for the first-line treatment of younger patients (7